Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

Background A quadruple therapy has been generally recommended as rescue regimen for
Helicobacter pylori eradication failures. Aims To systematically review the efficacy and …

Helicobacter pylori (H. pylori) remains a prevalent, worldwide, chronic infection. Though the
prevalence of this infection appears to be decreasing in many parts of the world, H. pylori …

Treatment failure is a major cause of concern for the Helicobacter pylori-related
gastroduodenal diseases like gastritis, peptic ulcer, and gastric cancer. Curcumin …

Aliment Pharmacol Ther 2012; 35: 209–221 Summary Background Even with the current
most effective treatment regimens, a relevant proportion of patients will fail to eradicate …

Abstract Rifaximin (4-deoxy-4)-methylpyrido [1), 2)-1, 2] imidazo-[5, 4-c]-rifamycin SV) is a
synthetic antibiotic designed to modify the parent compound, rifamycin, in order to achieve …

Nowadays, apart from having to know first-line Helicobacter pylori eradication regimens
well, we must also be prepared to face treatment failures. The aim of this review is to …

Helicobacter pylori infection may be the most common chronic bacterial infection worldwide.
Presently, it colonizes about 50% of the world's population, most commonly in individuals in …

Background: Recent years have witnessed a decrease in the rate of Helicobacter pylori
eradication due to antimicrobial resistance, clarithromycin or metronidazole resistance in …

Helicobacter pylori (H pylori) infection is the main cause of gastritis, gastroduodenal ulcer
disease, and gastric cancer. After more than 20 years of experience in H pylori treatment, in …